Welcome to Convatec

03-Feb-26

Corporate

Infusion Care

Update relating to Unomedical following United States Food and Drug Administr...

Update relating to Unomedical following United States FDA Remote Regulatory Assessment

16-Dec-25

Corporate

Advanced Wound Care

Convatec welcomes continued Medicare coverage for InnovaMatrix® in 2026 under...

Convatec welcomes continued Medicare coverage for InnovaMatrix® in 2026 under final LCDs on skin substitutes

01-Dec-25

Corporate

Continence Care

Ostomy Care

Convatec notes CMS decision on Medicare competitive bidding program in the Un...

CMS released a final rule outlining updates for the CY 2026 Medicare Home Health payment system and the DMEPOS CBP.

13-Nov-25

Corporate

Financial Performance

Trading update for the ten months ended 31 October 2025

Convatec announces its trading update for the ten months ended 31 October 2025.

06-Nov-25

Corporate

Our People

Chief Executive Officer and Chief Financial Officer appointments

The Board of Directors is pleased to announce the appointments of Jonny Mason and Fiona Ryder.

03-Nov-25

Corporate

Advanced Wound Care

Convatec notes CMS payment plans for skin substitutes in the United States

Convatec notes the Centers for Medicare & Medicaid Services (CMS) decision published on 31 October 2025

27-Oct-25

Corporate

Convatec announces Karim Bitar has passed away

Interim leadership arrangements remain in place and a further announcement will be made in due course

27-Oct-25

Corporate

Ostomy Care

Stigma, not condition, is the biggest barrier for 1 in 3 people living with c...

New report reveals that millions of people feel they need to hide their health conditions

01-Oct-25

Corporate

Convatec announces plans to invest more than $1 billion in R&D facilities – ...

Major expansions in the US and UK